The incidence of delirium in patients pretreated with statins who remain in an intensive care unit after cardiac surgery

Revista Brasileira de Terapia Intensiva

Volumn 24, Issue 1, 2012, Pages 52-57

  Da Cruz, Julia Niehues ^a   Tomasi, Cristiane Damiani ^b   Alves, Sarah Cascaes ^a,b   De MacEdo, Roberta Candal ^a,b   Giombelli, Vinícuis ^a,b   Da Cruz, José Geraldo Pereira ^c   Dal Pizzol, Felipe ^a,b   Ritter, Cristiane ^a,b  

^a HOSPITAL SÃO JOSÉ   (Brazil)

^b Health Sciences Unit   (Brazil)

^c REGIONAL UNIVERSITY OF BLUMENAU   (Brazil)

Author keywords

Cardiac surgery drug effects; Delirium etiology; Hydroxymethylglutaryl CoA reductase inhibitors adverse effects; Intensive care units; Postoperative period

Indexed keywords

EID: 84873907451     PISSN: 0103507X     EISSN: 19824335     Source Type: Journal    
DOI: 10.1590/S0103-507X2012000100008     Document Type: Article

References (20)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. text rev. Washington (DC): American Psychiatric Press; 2000.
2. Hshieh TT, Fong TG, Marcantonio ER, Inouye SK. Cholinergic deficiency hypothesis in delirium: a synthesis of current evidence. J Gerontol A Biol Sci Med Sci. 2008;63(7):764-72.
3. van der Mast RC. Delirium: the underlying pathophysiological mechanisms and the need for clinical research. J Psychosom Res. 1996;41(2):109-13.
4. Kazmierski J, Kowmana M, Banach M, Fendler W, Okonski P, Banys A, Jaszewski R, Rysz J, Mikhailidis DP, Sobow T, Kloszewska I; IPDACS Study. Incidence and predictors of delirium after cardiac surgery: results from The IPDACS Study. J Psychosom Res. 2010;69(2):179-85.
5. Redelmeier DA, Thiruchelvam, D, Daneman N. Delirium after elective surgery among elderly patients taking statins. CMAJ. 2008;179(7):645-52.
6. Katznelson R, Djaiani GN, Borger MA, Friedman Z, Abbey SE, Fedorko L, et al. Preoperative use of statins is associated with reduced early delirium rates after cardiac surgery. Anesthesiology. 2009;110(1):67-73.
7. Mathew JP, Grocott HP, McCurdy JR, Ti LK, Davis RD, Laskowitz DT, et al. Preoperative statin therapy does not reduce cognitive dysfunction after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2005;19(3):294-9.
8. Koenig MA, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, McKhann GM. Statin use and neurologic morbidity after coronary artery bypass grafting: A cohort study. Neurology. 2009;73(24):2099-106.
9. Kouroumichakis I, Papanas N, Proikaki S, Zarogoulidis P, Maltezos E. Statins in prevention and treatment of severe sepsis and septic shock. Eur J Intern Med. 2011;22(2):125-33.
10. Khemasuwan D, Chae YK, Gupta S, Carpio A, Yun JH, Neagu S, et al. Dose-related effect of statins in venous thrombosis risk reduction. Am J Med. 2011;124(9):852-9.
11. Blum A, Shamburek R. The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis. 2009;203(2):325-30.
12. Ely EW, Gautam S, Margolin R, Francis J, May L, Speroff T, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001;27(12):1892-900.
13. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med. 2001;27(5):859-64.
14. Rudolph JL, Jones RN, Grande LJ, Milberg WP, King EG, Lipsitz LA, et al. Impaired executive function is associated with delirium after coronary artery bypass graft surgery. J Am Geriatr Soc. 2006;54(6):937-41.
15. Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 2007;33(1):66-73.
16. Walzer T, Herrmann M, Wallesch CW, Starkstein SE, Herrmann M. Neuropsychological disorders after coronary bypass surgery. J Neurol Neurosurg Psychiatry. 1997;62(6):644-8.
17. Saheki A, Terasaki T, Tamai I, Tsuji A. In vivo and in vitro blood-brain barrier transport of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors. Pharm Res. 1994;11(2):305-11.
18. Botti RE, Triscari J, Pan HY, Zayat J. Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects. Clin Neuropharmacol. 1991;14(3):256-61.
19. Fassbender K, Stroick M, Bertsch T, Ragoschke A, Kuehl S, Walter S, et al. Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide. Neurology. 2002;59(8):1257-8.
20. Zacco A, Togo J, Spence K, Ellis A, Lloyd D, Furlongs S, Piser T. 3-hydroxi-3-methylglutaryl coenzime A reductase inhibitors protect cortical neurons from excitotoxicity. J Neurosci. 2003;23(35):11104-11.